tirzepatide what to expect first week How Adapt During the Month of Use? What to Expect After Your

gy tarts hsg esetn gyorsabban kiszradnak, hgutt is kaphatnak

14 A randomized, double-blind, parallel-group, placebo-controlled, superiority trial comparing semaglutide 1.0 mg against placebo therapy as an adjunct to standard of care on kidney outcomes in people with type 2 diabetes and chronic kidney disease, the decision to discontinue the trial was based on a recommendation from the trials independent Data Monitoring Committee indicating an interim analysis of the kidney outcomes trial for weekly semaglutide had met certain prespecified criteria for stopping the trial early for efficacy

The combination of monthly dosing, a new indication category (neuroscience instead of cardiometabolic), and the broader GLP-1-and-addiction signal is the most interesting pipeline development in this class right now

The drug is FDA-approved to treat type 2 diabetes in adults